BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33236974)

  • 1. Probiotic Lactobacilli Enhance Immunogenicity of an Inactivated H9N2 Influenza Virus Vaccine in Chickens.
    Alqazlan N; Astill J; Taha-Abdelaziz K; Nagy É; Bridle B; Sharif S
    Viral Immunol; 2021 Mar; 34(2):86-95. PubMed ID: 33236974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an inactivated influenza vaccine adjuvanted with Toll-like receptor ligands against transmission of H9N2 avian influenza virus in chickens.
    Raj S; Alizadeh M; Matsuyama-Kato A; Boodhoo N; Denis MS; Nagy É; Mubareka S; Karimi K; Behboudi S; Sharif S
    Vet Immunol Immunopathol; 2024 Feb; 268():110715. PubMed ID: 38219434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commensal gut microbiota can modulate adaptive immune responses in chickens vaccinated with whole inactivated avian influenza virus subtype H9N2.
    Yitbarek A; Astill J; Hodgins DC; Parkinson J; Nagy É; Sharif S
    Vaccine; 2019 Oct; 37(44):6640-6647. PubMed ID: 31542262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
    Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
    Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    BMC Res Notes; 2018 Jul; 11(1):428. PubMed ID: 29970157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine.
    Alizadeh M; Raj S; Shojadoost B; Matsuyama-Kato A; Boodhoo N; Abdelaziz K; Sharif S
    Vaccine; 2023 Nov; 41(48):7281-7289. PubMed ID: 37923694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
    Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadjuvant efficacy of CpG plasmids for H9N2 avian influenza inactivated vaccine in chickens with maternal antibodies.
    Pan X; Liu Q; de Jong MCM; Forlenza M; Niu S; Yan D; Teng Q; Li X; Beerens N; Li Z
    Vet Immunol Immunopathol; 2023 May; 259():110590. PubMed ID: 36990004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
    Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
    Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immune responses and protective efficacy elicited by oral administration AMP-ZnONPs-adjuvanted inactivated H9N2 virus in chickens.
    Liu X; Hong H; Wang J; Huang J; Li J; Tao Y; Liu M; Pang H; Li J; Bo R
    Poult Sci; 2024 Apr; 103(4):103496. PubMed ID: 38330890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
    Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
    Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
    Lone NA; Spackman E; Kapczynski D
    Vaccine; 2017 Jun; 35(26):3401-3408. PubMed ID: 28511853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG Oligodeoxynucleotides Facilitate Delivery of Whole Inactivated H9N2 Influenza Virus via Transepithelial Dendrites of Dendritic Cells in Nasal Mucosa.
    Qin T; Yin Y; Yu Q; Huang L; Wang X; Lin J; Yang Q
    J Virol; 2015 Jun; 89(11):5904-18. PubMed ID: 25810544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.